Bandingkan Harga & Kinerja Fimperkasa Utama Tbk. (FIMP) vs Merck Tbk. (MERK)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Fimperkasa Utama Tbk. dan Merck Tbk.: Fimperkasa Utama Tbk. diperdagangkan di Rp69 (kapitalisasi pasar 27,6 M), sedangkan Merck Tbk. diperdagangkan di Rp3.900 (kapitalisasi pasar 1,76 T, volume 24 jam 63 rb). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 63,8× kapitalisasi pasar Fimperkasa Utama Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| FIMP | MERK | |
|---|---|---|
Kapitalisasi Pasar | 27,6 M | 1,76 T |
Volume | — | 63 rb |
Lot | — | 630 |
Perputaran | — | 243,97 jt |
Harga Rata-rata | — | 3.872,46 |
Nilai Transaksi | — | 243,97 jt |
Harga Ekuilibrium Indikatif | — | 3.900 |
Volume Ekuilibrium Indikatif | — | 1 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Fimperkasa Utama Tbk.
PT Fimperkasa Utama Tbk (the "Company”) established in Indonesia based on Notarial Deed No. 41 of Adam Kasdarmadji, S.H., on February 08, 1993. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Mohamad Mulky Thalib,
Selengkapnya di halaman FIMP →Tentang Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →
